Treatment of primary central nervous system lymphoma with a combination of intraventricular administration of rituximab and systemic chemotherapy.

被引：0
|
作者：
Wang, Shujie
Zhang, Wei
Lian, Wei
Wu, Yongji
Zou, Nong
Zhu, Tienan
Zhou, Daobin
Xu, Ying
Shen, Ti
Zhao, Yongqiang
机构：
[1] Beijing Union Med Coll Hosp, Dept Hematol, Beijing, Peoples R China
[2] Beijing Union Med Coll Hosp, Dept Neurosurg, Beijing, Peoples R China
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4695
引用
收藏
页码：256B / 256B
页数：1
相关论文
共 50 条
  • [21] Chemotherapy of primary central nervous system lymphoma
    Delwail, V
    Bataille, B
    [J]. NEUROCHIRURGIE, 1997, 43 (06) : 380 - 384
  • [22] Intraventricular Rituximab in Pediatric CD20-positive Refractory Primary Central Nervous System Lymphoma
    Wada-Shimosato, Yuko
    Ikeda, Junji
    Tsujimoto, Shin-ichi
    Sasaki, Koji
    Yanagimachi, Masakatsu
    Kajiwara, Ryosuke
    Shiba, Norio
    Murata, Hidetoshi
    Kawahara, Nobutaka
    Yamanaka, Shoji
    Tanoshima, Reo
    Ito, Shuichi
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (07) : 571 - 573
  • [23] Cytomegalovirus Meningoencephalitis After Rituximab Treatment for Primary Central Nervous System Lymphoma
    Siakantaris, Marina P.
    Argyropoulos, Kimon V.
    Ioannou, Savvas
    Papadopoulou, Vasiliki
    Tzeletas, George
    Tsonis, John
    Dimitrakopoulou, Aglaia
    Yiannopoulou, Konstantina G.
    Pangalis, Gerassimos A.
    Vaiopoulos, George
    [J]. NEUROLOGIST, 2015, 19 (02) : 35 - 37
  • [24] Intraventricular Primary Central Nervous System Lymphoma Mimicking Ventriculitis
    Hirato, Tetsuya
    Komatsu, Kenichi
    Nishida, Namiko
    Matsumoto, Sadayuki
    [J]. INTERNAL MEDICINE, 2021, 60 (11) : 1797 - 1798
  • [25] Primary intraventricular central nervous system lymphoma in an immunocompetent patient
    Suri, Vinit
    Mittapalli, Venkatesh
    Kulshrestha, Manish
    Premlani, Kaushal
    Sogani, S. K.
    Suri, Kunal
    [J]. JOURNAL OF PEDIATRIC NEUROSCIENCES, 2015, 10 (04) : 393 - 395
  • [26] Chemotherapy is effective as early treatment for primary central nervous system lymphoma
    A. Boiardi
    Antonio Silvani
    Annalisa Pozzi
    Laura Fariselli
    Giovanni Broggi
    Andrea Salmaggi
    [J]. Journal of Neurology, 1999, 246 : 31 - 37
  • [27] Chemotherapy is effective as early treatment for primary central nervous system lymphoma
    Boiardi, A
    Silvani, A
    Pozzi, A
    Fariselli, L
    Broggi, G
    Salmaggi, A
    [J]. JOURNAL OF NEUROLOGY, 1999, 246 (01) : 31 - 37
  • [28] Complement Activation and Intraventricular Rituximab Distribution in Recurrent Central Nervous System Lymphoma
    Kadoch, Cigall
    Li, Jing
    Wong, Valerie S.
    Chen, Lingjing
    Cha, Soonmee
    Munster, Pamela
    Lowell, Clifford A.
    Shuman, Marc A.
    Rubenstein, James L.
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (04) : 1029 - 1041
  • [29] Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab
    Schulz, H
    Pels, H
    Schmidt-Wolf, I
    Zeelen, U
    Germing, U
    Engert, A
    [J]. HAEMATOLOGICA, 2004, 89 (06) : 753 - 754
  • [30] THE IMPACT OF RITUXIMAB COMBINATION CHEMOTHERAPY ON THE CLINICAL OUTCOMES OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): AN UPDATED META-ANALYSIS
    Haddad, Philip
    Hammoud, Dalia
    Gallagher, Kevin
    [J]. NEURO-ONCOLOGY, 2020, 22 : 84 - 84
12345